Skip to content
DataLookout
Menu

NCT06594289

Evaluation of the Safety and Effectiveness of Pringle Method Combined With IVC Flow Limiting and Blocking Method in Laparoscopic Hepatectomy Based on Non-restrictive Fluid Therapy Strategy

StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Intraoperative blood loss
Timeframe: Up to approximately 20 months:September 2024 - May 2026
Intraoperative central venous pressure
Timeframe: Up to approximately 20 months:September 2024 - May 2026

Secondary (4)

Level of aminotransferase
level of Lactic acid
Blood Sugar level
level of creatinine

Arms and interventions

Control groupNo intervention

Group A (Pringle method + restricted fluid management + use of vasoactive drugs by anesthesiologists) : The means of use and anesthetic drugs in this group were all conventional technical means without special intervention, so it was the control group.

Observation groupExperimental

Group B (Pringle method +IVC flow limiting and blocking method + open fluid intake during operation; Observation group: Patients in this group did not use anesthesia related drugs to control CVP, so they should strictly communicate with the anesthesiologist, and achieve homogeneity in the use of vasoactive drugs and narcotic drugs.

Procedures: In laparoscopic hepatectomy, the subhepatic inferior vena cava was restricted and the patient was given non-restricted intraoperative fluid intake

Sites

1 site in 1 country

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuangzhou, China/Guangdong, China